Literature DB >> 15084544

Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium.

M Bountioukos1, A F L Schinkel, J J Bax, V Rizzello, R Valkema, B J Krenning, E Biagini, E C Vourvouri, J R T C Roelandt, D Poldermans.   

Abstract

OBJECTIVES: To assess whether quantification of myocardial systolic velocities by pulsed wave tissue Doppler imaging can differentiate between stunned, hibernating, and scarred myocardium.
DESIGN: Observational study.
SETTING: Tertiary referral centre. PATIENTS: 70 patients with reduced left ventricular function caused by chronic coronary artery disease.
METHODS: Pulsed wave tissue Doppler imaging was done close to the mitral annulus at rest and during low dose dobutamine; systolic ejection velocity (Vs) and the difference in Vs between low dose dobutamine and the resting value (DeltaVs) were assessed using a six segment model. Assessment of perfusion (with Tc-99m-tetrofosmin SPECT) and glucose utilisation (by 18F-fluorodeoxyglucose SPECT) was used to classify dysfunctional regions (by resting cross sectional echocardiography) as stunned, hibernating, or scarred.
RESULTS: 253 of 420 regions (60%) were dysfunctional. Of these, 132 (52%) were classified as stunned, 25 (10%) as hibernating, and 96 (38%) as scarred. At rest, Vs in stunned, hibernating, and scar tissue was, respectively, 6.3 (1.8), 6.6 (2.2), and 5.5 (1.5) cm/s (p = 0.001 by ANOVA). There was a gradual decline in Vs during low dose dobutamine infusion between stunned, hibernating, and scar tissue (8.3 (2.6) v 7.8 (1.5) v 6.8 (1.9) cm/s, p < 0.001 by ANOVA). DeltaVs was higher in stunned (2.1 (1.9) cm/s) than in hibernating (1.2 (1.4) cm/s, p < 0.05) or scarred regions (1.3 (1.2) cm/s, p = 0.001).
CONCLUSIONS: Quantitative tissue Doppler imaging showed a gradual reduction in regional velocities between stunned, hibernating, and scarred myocardium. Dobutamine induced contractile reserve was higher in stunned regions than in hibernating and scarred myocardium, reflecting different severities of myocardial damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084544      PMCID: PMC1768236          DOI: 10.1136/hrt.2003.018531

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  23 in total

1.  Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.

Authors:  R Rambaldi; D Poldermans; J J Bax; E Boersma; A Elhendy; W Vletter; J R Roelandt; R Valkema
Journal:  Eur Heart J       Date:  2000-07       Impact factor: 29.983

2.  Performance characteristics of a 511-keV collimator for imaging positron emitters with a standard gamma-camera.

Authors:  A van Lingen; P C Huijgens; F C Visser; G J Ossenkoppele; O S Hoekstra; H J Martens; H Huitink; K D Herscheid; M V Green; G J Teule
Journal:  Eur J Nucl Med       Date:  1992

3.  Relationship between preoperative viability and postoperative improvement in LVEF and heart failure symptoms.

Authors:  J J Bax; F C Visser; D Poldermans; A Elhendy; J H Cornel; E Boersma; R Valkema; A Van Lingen; P M Fioretti; C A Visser
Journal:  J Nucl Med       Date:  2001-01       Impact factor: 10.057

4.  Time course of functional recovery of stunned and hibernating segments after surgical revascularization.

Authors:  J J Bax; F C Visser; D Poldermans; A Elhendy; J H Cornel; E Boersma; A van Lingen; P M Fioretti; C A Visser
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

5.  Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium.

Authors:  J L Vanoverschelde; W Wijns; C Depré; B Essamri; G R Heyndrickx; M Borgers; A Bol; J A Melin
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

6.  Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.

Authors:  Arend F L Schinkel; Jeroen J Bax; Ron van Domburg; Abdou Elhendy; Roelf Valkema; Eleni C Vourvouri; Fabiola B Sozzi; Jos R T C Roelandt; Don Poldermans
Journal:  J Nucl Med       Date:  2003-02       Impact factor: 10.057

Review 7.  A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina.

Authors:  S H Rahimtoola
Journal:  Circulation       Date:  1985-12       Impact factor: 29.690

8.  Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy.

Authors:  Roxy Senior; Sanjiv Kaul; Usha Raval; Avijit Lahiri
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

9.  A canine model of chronic ischemic cardiomyopathy: characterization of regional flow-function relations.

Authors:  S Firoozan; K Wei; A Linka; D Skyba; N C Goodman; S Kaul
Journal:  Am J Physiol       Date:  1999-02

10.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography.

Authors:  D Eitzman; Z al-Aouar; H L Kanter; J vom Dahl; M Kirsh; G M Deeb; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1992-09       Impact factor: 24.094

View more
  4 in total

Review 1.  Echocardiography in the assessment of left ventricular longitudinal systolic function: current methodology and clinical applications.

Authors:  Valerio Zacà; Piercarlo Ballo; Maurizio Galderisi; Sergio Mondillo
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

Review 2.  Mitochondrial-Targeted Molecular Imaging in Cardiac Disease.

Authors:  Jinhui Li; Jing Lu; You Zhou
Journal:  Biomed Res Int       Date:  2017-05-30       Impact factor: 3.411

3.  Myocardial viability: what we knew and what is new.

Authors:  Adel Shabana; Ayman El-Menyar
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

Review 4.  Taxonomy of segmental myocardial systolic dysfunction.

Authors:  Adam K McDiarmid; Pierpaolo Pellicori; John G Cleland; Sven Plein
Journal:  Eur Heart J       Date:  2017-04-01       Impact factor: 29.983

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.